CRS - IPTS Workshop on Vaccine Development

Chairs: Sevda Şenel and Gerrit Borchard

Infectious diseases are one of the foremost causes of death worldwide. The recent experiences with various flu epidemics reveal the global aspects of both disease and treatment. In this regard, vaccination is by far the most effective strategy to not merely treat but actually prevent disease and its spread. Vaccination strategies today not only address infectious disease but also are employed therapeutically, e.g., cancer.

To quickly respond to the threat of emerging infectious diseases, as well as to increase the efficiency of vaccination against existing diseases, new vaccines, novel adjuvants, and new vaccine delivery systems are being developed. These must be submitted to a rigorous regulatory process, which may pose a challenge, especially to the development of new adjuvants and delivery systems.

This workshop is dedicated to discussing current issues in vaccine development from the perspective of experts in the field from academia, regulatory, and industry.

In addition to the plenary lectures, a poster session will give participating scientits the opportunity to present their recent results on vaccine formulation, and provide a platform for information exchange between academia and industry. Those who wish to contribute a poster presentation are requested to follow the instructions given on the website of IPTS (http://ipts-hacettepe.org/content/guidelines-abstracts).

11 September 2010, Saturday
08:30-10:00	Registration
10:00-10:15	Opening
10:15-11:00	Future of vaccine research John Shiver (Merck and Co., Inc., Worldwide Basic Research Franchise Head, Vaccines, West Point, PA, USA)
11:00-11:45	Optimising microparticle and nanoparticle adjuvants to enhance immunity to vaccines Ed Lavelle (Trinity College, School of Biochemistry and Immunology, Dublin, Ireland)
11:45-12:15	Coffee break and posters
12:15-13:00	Vaccine adjuvants for emerging sexually transmitted infections: Lessons from genital herpes Ali Harandi (University of Gothenburg, Department of Microbiology and Immunology, Gothenburg, Sweden)
13:00-14:30	Lunch and posters
14:30-15:15	Recent advances in vaccine adjuvants - an overview Barbara Baudner (Novartis Vaccines, Sienna, Italy)
15:15-16:00	Challenges and opportunities in pulmonary delivery of vaccines Gerrit Borchard (University of Geneva, School of Pharmaceutical Sciences Geneva-Lausanne (EPGL), Geneva, Switzerland)

12 September 2010, Sunday
09:00-09:45	Non-invasive vaccine delivery across the skin Joke Bouwstra (Leiden/Amsterdam Center for Drug Research, Department of Drug Delivery Technology, Leiden, The Netherlands
09:45-10:30	Nasal vaccine delivery Oya Alpar (University of London, The School of Pharmacy, Centre for Drug Delivery Research, London, UK)
10:30-10:45	Coffee break and posters
10:45-11:30	Chitosan for vaccine delivery Sevda Şenel (Hacettepe University, Faculty of Pharmacy, Department of Pharmaceutical Technology, Ankara, Turkey)
11:30-12:00	Panel discussion- Future of vaccine formulations

Registration

	Regular attendee*	Student
IPTS Meeting + Workshop	600 euros	275 euros
Workshop Only	300 euros	150 euros

Accommodation

	Before July 30th, 2010	After July 30th, 2010
Single Room	265 euros	285 euros
Per Person in Double Room	180 euros	200 euros